Belinostat
ADVERTISEMENT
- Molecular formula
- C8H15N3O4
- CAS Number
- 414864-00-9
- IUPAC Name
- N-[4-[[1-(hydroxycarbamoyl)-2-methyl-propyl]-(2-morpholinoethyl)sulfamoyl]phenyl]-4-pentyl-benzamide
- Molecular Weight
- 318.15g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 0.9736g/cm3
Identification
Interesting facts
Interesting Facts about N-[4-[[1-(hydroxycarbamoyl)-2-methyl-propyl]-(2-morpholinoethyl)sulfamoyl]phenyl]-4-pentyl-benzamide
N-[4-[[1-(hydroxycarbamoyl)-2-methyl-propyl]-(2-morpholinoethyl)sulfamoyl]phenyl]-4-pentyl-benzamide is a compound that showcases the fascinating complexities of organic chemistry and drug design. Here are some interesting insights about this compound:
- Multifunctionality: The structure of this compound incorporates various functional groups, including amides and sulfamides, which can enhance its interaction with biological targets.
- Potential Therapeutic Use: Given its unique chemical structure, this compound may have applications in drug formulation, particularly in areas requiring innovative therapies for conditions like cancer or diabetes.
- Structure-Activity Relationship (SAR): Chemists often explore how slight modifications in the compound’s structure can affect its biological activity, providing insight into optimizing pharmacological effects.
- Design Challenges: The complexity of such compounds presents numerous challenges during synthesis and characterization, making it a fascinating topic of study in both synthetic and medicinal chemistry.
- Research Frontiers: Compounds like this one are often at the forefront of research into new drug candidates, emphasizing the importance of continual chemical exploration and innovation.
In summary, N-[4-[[1-(hydroxycarbamoyl)-2-methyl-propyl]-(2-morpholinoethyl)sulfamoyl]phenyl]-4-pentyl-benzamide represents an exciting intersection of chemistry and medicine, illustrating how compounds can be designed for specific biological activities. As scientists continue to unravel the potential of such molecules, we can expect to see significant advances in therapeutic treatments.